Fritextsökning
Artiklar per år
Innehållstyper
-
S2 Medical rekryterar finanschef
Oskar Johansson blir finanschef på det Linköpingsbaserade företaget.
-
Pharmarelations växer i Sverige och Danmark
Konsult- och interimsföretaget Pharmarelations har nyrekryterat till företagets svenska och danska team.
-
Obligation ska rädda företag från corona
Världsbanken delar ut 83 miljarder till strategiska sektorer, däribland life science-branschen.
-
Swedish and Danish Life Science – are there still untapped synergies?
With the increasing developments in life sciences over the past decade and strong support for the sector’s strategic importance from both the Sweden and Danish governments, the timing of The Future of Swedish & Danish Life Science conference could not be better. A one-day conference on ongoing collaborations, new directions and required future investment will held on April 2nd at Medicon Village in Lund.
-
Ny chef på Nanexa
Björn Svanström är företagets nya finanschef.
-
Krönika: Can regulators keep up with innovation?
New technology has increased the understanding of disease mechanisms and enabled approval of products targeting small but specific patient populations; sometimes referred to as precision medicine. Gene- and cell therapies have reached the market, exemplified by CAR-T cells, and the research pipeline is promising. In addition, the medical device field is constantly growing creating new solutions to address patient needs.